BRAINTREE - Haemonetics Corp., a maker of blood collection and processing systems, reported third-quarter results that fell short of Wall Street’s expectations. That, plus a $60 million all-cash buyout of a health information technology company, sent the company’s shares tumbling yesterday.
Haemonetics swill buy all outstanding common shares of Global Med Technologies Inc. for $1.22 each and its preferred stock at about $1,694 per share. It expects to have more than $100 million left at the end of its fiscal year.
Shares of Haemonetics sank just over 6 percent, or $3.42, to $53.19.
Haemonetics said it earned $18.3 million, or 71 cents per share, on $165.2 million in revenue for the quarter that ended Dec. 26. That compares with earnings of $16.2 million, or 62 cents, on $155.4 million in revenue for the same quarter of 2008.
